XML 133 R105.htm IDEA: XBRL DOCUMENT v3.22.4
RESTATEMENT - Statement of Operations (Details) - USD ($)
 3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Jun. 30, 2022
Mar. 31, 2022
Dec. 31, 2021
Mar. 31, 2022
Jun. 30, 2022
Sep. 30, 2022
Sep. 30, 2021
RESTATEMENT              
Loss from Operations $ (18,221,165) $ (30,452,870) $ (14,058,407) $ (44,511,277) $ (62,732,442) $ (96,989,096) $ (22,402,168)
Other financing costs - initial recognition of warrants at fair value 41,250,395 2,120,515 22,405,532 24,526,046 65,776,422   1,559,961
Loss on financing   (160,364,949) (6,282,494) (269,344,178) (269,344,178) (484,421,258)  
Revaluation of warrants 31,538,523 (131,670,146) (10,618,382) (142,288,528) (110,750,005) 122,803,715  
Others (41,250,395) (2,120,515) (22,405,532) (24,526,046) (65,776,422)   (1,559,961)
Other income (expense), net (9,711,872) (294,155,610) (142,003,144) (436,158,753) (445,870,606) (5,647,841)  
Net Loss (27,933,037) (324,608,480) $ (156,061,551) (480,670,030) (508,603,048) (739,532,806) (44,240,580)
Deemed dividend on preferred stock   (32,735,345)   (32,735,345) (32,735,345) (40,516,440)  
Net loss attributable to common stockholders $ (27,933,037) $ (357,343,825)   $ (513,405,375) $ (541,338,393) $ (780,049,246) $ (44,240,580)
Loss per Share, Basic $ (0.07) $ (6.95) $ (8.93) $ (14.82) $ (3.19) $ (2.80) $ (8.56)
Weighted average shares outstanding, basic 376,786,685 51,392,988 17,471,173 34,639,857 169,531,688 278,219,500 5,171,144
As Previously Reported              
RESTATEMENT              
Loss from Operations $ (18,221,165) $ (30,452,870) $ (14,058,407) $ (44,511,277) $ (62,732,442)    
Other financing costs - initial recognition of warrants at fair value 41,250,395 2,120,515 22,405,532 24,526,046 65,776,422    
Series E Options Liability (23,085,886)       (23,085,886)    
Others (41,250,395) (2,120,515) (22,405,532) (24,526,046) (65,776,422)    
Other income (expense), net (64,336,281) (2,120,515) (22,405,532) (24,526,046) (88,862,308)    
Net Loss (82,557,446) (32,573,385) $ (36,463,939) (69,037,323) (151,594,750)    
Net loss attributable to common stockholders $ (82,557,446) $ (32,573,385)   $ (69,037,323) $ (151,594,750)    
Loss per Share, Basic $ (0.22) $ (0.63) $ (2.09) $ (1.99) $ (0.89)    
Weighted average shares outstanding, basic 376,786,685 51,392,988 17,471,173 34,639,857 169,531,688    
Adjustments              
RESTATEMENT              
Loss on financing   $ (160,364,949) $ (108,979,229) $ (269,344,178) $ (269,344,178)    
Revaluation of warrants $ 31,538,523 (131,670,146) (10,618,382) (142,288,528) (110,750,005)    
Series E Options Liability 23,085,886       23,085,886    
Other income (expense), net 54,624,409 (292,035,095) (119,597,612) (411,632,707) (357,008,298)    
Net Loss 54,624,409 (292,035,095) $ (119,597,612) (411,632,707) (357,008,298)    
Deemed dividend on preferred stock   (32,735,345)   (32,735,345) (32,735,345)    
Net loss attributable to common stockholders $ 54,624,409 $ (324,770,440)   $ (444,368,052) $ (389,743,643)